FUSION ANTIBODIES PLC
CRO providing end-to-end services for preclinical antibody development.
FAB | IL
Overview
Corporate Details
- ISIN(s):
- GB00BDQZGK16
- LEI:
- 213800KBAYRC9VOQ9V39
- Country:
- United Kingdom
- Address:
- 1 SPRINGBANK ROAD, BT17 0QL BELFAST
Description
Fusion Antibodies PLC is a contract research organization (CRO) that provides a comprehensive suite of services for the discovery, engineering, and supply of preclinical biologics. The company offers an integrated, end-to-end antibody development platform, spanning from initial antigen design and antibody generation to advanced engineering processes like humanization and affinity maturation. It also provides services for the supply of recombinant proteins and antibodies, including stable cell line development. Fusion Antibodies supports therapeutic and diagnostic programs, operating as a collaborative partner to guide projects through critical preclinical stages with a focus on long-term manufacturability and commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-11 08:25 |
Mammalian Display video
|
English | 24.5 KB | ||
| 2025-11-25 13:25 |
Holding(s) in Company
|
English | 21.0 KB | ||
| 2025-11-24 08:15 |
Half-year Financial Report
|
English | 225.3 KB | ||
| 2025-11-21 08:25 |
Notice of Results
|
English | 17.0 KB | ||
| 2025-11-13 08:30 |
OptiMAL Library video
|
English | 16.9 KB | ||
| 2025-11-03 08:20 |
OptiMAL® R&D Update
|
English | 16.5 KB | ||
| 2025-10-27 16:38 |
Holding(s) in Company
|
English | 22.0 KB | ||
| 2025-10-16 14:31 |
Result of AGM
|
English | 15.7 KB | ||
| 2025-10-16 08:00 |
AGM statement and H1 trading update
|
English | 17.4 KB | ||
| 2025-09-19 13:58 |
Posting of Annual Report & Notice of AGM
|
English | 14.2 KB | ||
| 2025-09-17 08:00 |
OptiMAL R&D Update
|
English | 21.3 KB | ||
| 2025-09-08 08:00 |
Belfast investor presentation
|
English | 15.2 KB | ||
| 2025-09-04 08:00 |
Final Results
|
English | 439.7 KB | ||
| 2025-07-24 11:56 |
Issue Notification: US Patent Update
|
English | 14.4 KB | ||
| 2025-07-11 08:00 |
Director/PDMR Shareholding
|
English | 24.7 KB |
Automate Your Workflow. Get a real-time feed of all FUSION ANTIBODIES PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FUSION ANTIBODIES PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FUSION ANTIBODIES PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
